Tekce, GirayArican, MehmetKaraduman, Zekeriya OkanTurhan, YalcinSaglam, SonmezYucel, Muecahid OsmanCoskun, Sinem Kantarcioglu2024-08-232024-08-2320240028-12981432-1912https://doi.org/10.1007/s00210-024-03147-yhttps://hdl.handle.net/20.500.12684/14555Fracture healing is a process in which many factors interact. In addition to many treatments, physical and biological therapy methods that affect different steps of this process, there are many biological and chemical agents that cause fracture union delay. Although the number of studies on fracture healing is increasing day by day, the mechanism of fracture healing, which is not fully understood, still attracts the attention of all researchers. In this study, we aimed to investigate the effects of favipiravir and hydroxychloroquine used in the treatment of COVID-19. In this study, 48 male Wistar rats weighing 300 +/- 50 g were used. Each group was divided into eight subgroups of six rats each to be sacrificed at the 2nd and 4th weeks and evaluated radiologically and histologically. Favipiravir (group 1), hydroxychloroquine (group 2), favipiravir + hydroxychloroquine (group 3), and random control (group 4) were used. A statistically significant difference was observed between the 15th day histological scoring averages of the groups (p < 0.05). Although there was no statistically significant difference between the 15th day radiological score distributions of the groups (p > 0.05), we obtained different results in terms of complete bone union distributions and radiological images of the fracture line. Although favipiravir has a negative effect on fracture union in the early period, favipiravir may have a positive effect on fracture union in the late period. We did not find any effect of hydroxychloroquine on fracture union.en10.1007/s00210-024-03147-yinfo:eu-repo/semantics/openAccessFracture healingHydroxychloroquineRatFavipiravirT-705CareArticle387431162-s2.0-85192935691WOS:001222579200001Q2N/A